177 related articles for article (PubMed ID: 2433654)
21. Investigation of the effect of mistletoe (Viscum album L.) extract Iscador on the proliferation and apoptosis of murine thymocytes.
Hajtò T; Berki T; Pàlinkàs L; Boldizsàr F; Németh P
Arzneimittelforschung; 2006 Jun; 56(6A):441-6. PubMed ID: 16927524
[TBL] [Abstract][Full Text] [Related]
22. Mistletoe extract-induced effects on immunocompetent cells: in vitro studies.
Stein GM; Berg PA
Anticancer Drugs; 1997 Apr; 8 Suppl 1():S39-42. PubMed ID: 9179366
[TBL] [Abstract][Full Text] [Related]
23. Immunomodulatory effects of Viscum album agglutinin-I on natural immunity.
Hajto T; Hostanska K; Fischer J; Saller R
Anticancer Drugs; 1997 Apr; 8 Suppl 1():S43-6. PubMed ID: 9179367
[TBL] [Abstract][Full Text] [Related]
24. Immunomodulatory effects of Viscum album extracts on natural killer cells: review of clinical trials.
Braedel-Ruoff S
Forsch Komplementmed; 2010 Apr; 17(2):63-73. PubMed ID: 20484913
[TBL] [Abstract][Full Text] [Related]
25. Immunomodulatory activity of a peptide isolated from Viscum album extract (NSC 635 089).
Kuttan G; Kuttan R
Immunol Invest; 1992 Jul; 21(4):285-96. PubMed ID: 1398778
[TBL] [Abstract][Full Text] [Related]
26. Absence of tumor growth stimulation in a panel of 26 human tumor cell lines by mistletoe (Viscum album L.) extracts Iscador in vitro.
Kelter G; Fiebig HH
Arzneimittelforschung; 2006 Jun; 56(6A):435-40. PubMed ID: 16927523
[TBL] [Abstract][Full Text] [Related]
27. Comparison of the effects of fermented and unfermented mistletoe preparations on cultured tumor cells.
Ribéreau-Gayon G; Jung ML; Di Scala D; Beck JP
Oncology; 1986; 43 Suppl 1():35-41. PubMed ID: 3808575
[TBL] [Abstract][Full Text] [Related]
28. Viscotoxins, mistletoe lectins and their isoforms in mistletoe (Viscum album L.) extracts Iscador.
Urech K; Schaller G; Jäggy C
Arzneimittelforschung; 2006 Jun; 56(6A):428-34. PubMed ID: 16927522
[TBL] [Abstract][Full Text] [Related]
29. Improvement of DNA repair in lymphocytes of breast cancer patients treated with Viscum album extract (Iscador).
Kovacs E; Hajto T; Hostanska K
Eur J Cancer; 1991; 27(12):1672-6. PubMed ID: 1782081
[TBL] [Abstract][Full Text] [Related]
30. An overview on anticancer activities of the Viscum album extract Isorel.
Zarkovic N; Vukovic T; Loncaric I; Miletic M; Zarkovic K; Borovic S; Cipak A; Sabolovic S; Konitzer M; Mang S
Cancer Biother Radiopharm; 2001 Feb; 16(1):55-62. PubMed ID: 11279798
[TBL] [Abstract][Full Text] [Related]
31. Biologic properties of iscador: a Viscum album preparation I. Hyperplasia of the thymic cortex and accelerated regeneration of hematopoietic cells following X-irradiation.
Rentea R; Lyon E; Hunter R
Lab Invest; 1981 Jan; 44(1):43-8. PubMed ID: 7453129
[TBL] [Abstract][Full Text] [Related]
32. Isolation and identification of a tumour reducing component from mistletoe extract (Iscador).
Kuttan G; Vasudevan DM; Kuttan R
Cancer Lett; 1988 Aug; 41(3):307-14. PubMed ID: 3409209
[TBL] [Abstract][Full Text] [Related]
33. Donor-dependent and dose-dependent variation in the induction of T lymphocyte locomotion in a three-dimensional collagen matrix system by a mistletoe preparation (Iscador).
Nikolai G; Friedl P; Werner M; Zänker KS
Anticancer Drugs; 1997 Apr; 8 Suppl 1():S61-4. PubMed ID: 9179371
[TBL] [Abstract][Full Text] [Related]
34. Anticarcinogenic and antimetastatic activity of Iscador.
Kuttan G; Menon LG; Antony S; Kuttan R
Anticancer Drugs; 1997 Apr; 8 Suppl 1():S15-6. PubMed ID: 9179361
[TBL] [Abstract][Full Text] [Related]
35. Mistletoe (viscum album) lectins as cytokine inducers and immunoadjuvant in tumor therapy. A review.
Bocci V
J Biol Regul Homeost Agents; 1993; 7(1):1-6. PubMed ID: 8346712
[TBL] [Abstract][Full Text] [Related]
36. Characterization of a toxic lectin in Iscador, a mistletoe preparation with alleged cancerostatic properties.
Holtskog R; Sandvig K; Olsnes S
Oncology; 1988; 45(3):172-9. PubMed ID: 3368193
[TBL] [Abstract][Full Text] [Related]
37. Influence of Viscum album preparations on the natural killer cell-mediated cytotoxicity of peripheral blood.
Hülsen H; Kron R; Mechelke F
Naturwissenschaften; 1989 Nov; 76(11):530-1. PubMed ID: 2615845
[No Abstract] [Full Text] [Related]
38. Prospective controlled cohort studies on long-term therapy of ovairian cancer patients with mistletoe (Viscum album L.) extracts iscador.
Grossarth-Maticek R; Ziegler R
Arzneimittelforschung; 2007; 57(10):665-78. PubMed ID: 18074761
[TBL] [Abstract][Full Text] [Related]
39. Preclinical investigations with mistletoe (Viscum album L.) extract Iscador.
Maldacker J
Arzneimittelforschung; 2006 Jun; 56(6A):497-507. PubMed ID: 16927531
[TBL] [Abstract][Full Text] [Related]
40. Pleura carcinosis. Cytomorphological findings with the mistletoe preparation iscador and other pharmaceuticals.
Salzer G
Oncology; 1986; 43 Suppl 1():66-70. PubMed ID: 3808576
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
